Hyperbaric oxygen therapy for long COVID: a prospective registry
Authors:
Open Access
- 4 August 2025
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 28351
Abstract
A potential beneficial effect of hyperbaric oxygen therapy (HBOT) on complaints of long COVID was found, leading to increased demand for this treatment despite many remaining clinical questions and lack of formal guideline recommendations and reimbursement. A registry was set up in order to gain more insight into patient characteristics and (long-term) outcomes of long COVID patients undergoing HBOT. Patient-reported outcome measures were collected at baseline, after treatment, at 3-month and 1-year follow up. This publication includes the 3-month results. The primary outcome measures were the mental and physical component score (MCS/PCS) of the SF-36 questionnaire. A clinically relevant positive or negative response was defined as a ≥ 10 point increase or decrease of in MCS and/or PCS after 3 months. Secondary outcomes included the EQ-5D, severity of complaints and ability to work. In this prospective registry, 56-63% of long term-ill patients had a clinically relevant improvement in MCS/PCS 3 months after HBOT. However, 13-19% of the patients had a clinically relevant deterioration in MCS/PCS. Symptoms that showed most improvement were predominantly in the cognitive domain. This indicates that HBOT may have a positive effect on complaints of long COVID, but alertness for worsening of the condition should be exercised.Keywords
This publication has 24 references indexed in Scilit:
- StatPearls2023
- Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: A randomized, sham-controlled trialNeuroImage: Clinical, 2022
- Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trialScientific Reports, 2022
- A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus studyThe Lancet Respiratory Medicine, 2022
- Hyperbaric oxygen treatment for long coronavirus disease-19: a case reportJournal of Medical Case Reports, 2022
- Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising interventionClinical Medicine, 2021
- Hyperbaric Oxygen Increases Stem Cell Proliferation, Angiogenesis and Wound-Healing Ability of WJ-MSCs in Diabetic MiceFrontiers in Physiology, 2018
- Hyperbaric oxygen may induce angiogenesis in patients suffering from prolonged post-concussion syndrome due to traumatic brain injuryRestorative Neurology and Neuroscience, 2015
- Hyperbaric Oxygen Induces Late Neuroplasticity in Post Stroke Patients - Randomized, Prospective TrialPLOS ONE, 2013
- Protection of mitochondrial function and improvement in cognitive recovery in rats treated with hyperbaric oxygen following lateral fluid-percussion injuryJournal of Neurosurgery, 2007